Corneal Collagen Cross-Linking for Ectasia (CXL)

Completed · Phase 3

Conditions studied: Ectasia

In brief

Prospective, randomized multicenter study to determine the safety and effectiveness of performing corneal collagen cross-linking (CXL) using riboflavin and UVA light in eyes with ectasia after refractive surgery.

Key facts

Study ID

NCT00674661

Run by

Glaukos Corporation

People needed

130

Starts

2007-12-01

Expected to finish

2011-11-01

Last updated by the study team

2021-04-26

Who can join

Age: 14 and older. Sex: any. Healthy volunteers: not accepted.

You may qualify if…

• Diagnosis of ectasia after refractive surgery
• Documented ectasia on Pentacam or topography map
• BSCVA worse than 20/20
• Must complete all study visits

You may not qualify if…

• History of delayed wound healing
• History of corneal melt or corneal dystrophy

Where it is running

• Shiley Eye Center — La Jolla, California, United States
• Gordon -Weiss Vision Institute — San Diego, California, United States
• Center for Excellence in Eye Care — Miami, Florida, United States
• Price Vision Group — Indianapolis, Indiana, United States
• Durrie Vision — Kansas City, Kansas, United States
• Wilmer Eye Institute at Johns Hopkins University — Baltimore, Maryland, United States
• Minnesota Eye Consultants — Minneapolis, Minnesota, United States
• Cornea & Laser Eye Institute; Hersh Vision Group — Teaneck, New Jersey, United States
• Edward Harkness Eye Institute at Columbia University Medical Center — New York, New York, United States
• Ophthalmic Consultants of Long Island — Rockville Centre, New York, United States

Full record on ClinicalTrials.gov

Trial information comes from ClinicalTrials.gov and is refreshed daily. TrialsForMe does not provide medical care and does not run the studies it lists.